Location Cupertino, California, United States Regions San Francisco Bay Area, Silicon Valley, West Coast Gender Male
LinkedIn View on LinkedIn
Dr. Queen has extensive experience in conducting and directing research in molecular biology and immunology, especially for the development of antibodies as therapeutic agents. He was co-founder of Protein Design Labs, Inc. (PDL), where he invented fundamental technology for the humanization of antibodies which has been widely licensed and used,
for example, in the drugs Herceptin® and Avastin®. He led the research team that developed Zenapax®, the first humanized antibody to be approved by the FDA. While a senior executive and Board member of PDL, he participated in all aspects of corporate decision-making and at various times oversaw the research, development, manufacturing, preclinical and clinical areas.
